OFFICIAL PUBLICATION OF

by its subsidiary APPco

Research Roundup

Debbie Rigby 05/05/2026

Debbie Rigby rounds up the latest research news GLP-1 Receptor/Dual Agonists for Weight Loss A systematic review and network meta-analysis of 127 RCTs concluded that tirzepatide and semaglutide are most effective GLP-1 receptor agonists in adults with and without type 2 diabetes for clinically meaningful weight loss. For ≥ 10% loss, tirzepatide was most effective. Diabetes,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

HMR safety: ‘What are we waiting for?’

Another risk management strategy would be to expect or require that referrers, who presumably have a more extensive knowledge of…

Tim Hewitt

‘Heartbreaking’ case highlights need for support: Guild Insurance

Yes indemnity insurance covers these things but there can be delays in the process and costs are ongoing. Guild Insurance…

Kay Dunkley

Violent assault in Melbourne pharmacy

From past experience the only way you get an immediate response from the police is to suggest that person is/thought…

Tony Lee

‘Heartbreaking’ case highlights need for support: Guild Insurance

Aren’t these things that should be paid for by the pharmacist’s indemnity insurance? Isn’t that the whole point? The only…

John Smith

Research Roundup

Previous Ahpra revises criminal history rego standard

This is the most recent story.

Research Roundup

dRx series: Deprescribing teriparatide in older people

Contact dermatitis from daily skincare routines

dRx series: Deprescribing thyroxine in older people

MENU

Previous Ahpra revises criminal history rego standard

This is the most recent story.

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.